Eli Lilly to invest over $1 billion in India to expand manufacturing capacity

Eli Lilly will invest over $1 billion in India to boost manufacturing and supply through local drugmakers, increasing the availability of key drugs like Mounjaro. This strategic move leverages India's skilled workforce and includes a new Hyderabad facility to oversee contract manufacturing, despite global shifts towards US production.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xzfFbtB
via IFTTT